Purificación Cid‐Silva

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

Purificación Cid‐Silva, Noelia Fernández Bargiela, Luis Margusino‐Framiñán et al. · Basic & Clinical Pharmacology & Toxicology · 2018 · 47 citations

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in <scp>HIV</scp>‐infected Patients: Efficacy, Safety and Tolerance

Purificación Cid‐Silva, Josep M. Llibre, Noelia Fernández Bargiela et al. · Basic & Clinical Pharmacology & Toxicology · 2017 · 36 citations · Full text

Immunodeficiencies, Pharmacotherapy, Antiviral Drug +20

Late HIV Diagnosis but EarlierAntiretroviral Treatment Initiationin Northwest Spain: Impact of CurrentTreatment Guidelines

Purificación Cid‐Silva, Luis Margusino‐Framiñán, Vanesa Balboa‐Barreiro et al. · 2019 · 31 citations

Currenttreatment Guidelines, Hiv/aids Counselling, Treatment And Prevention +8

Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients

Iria Rodríguez-Osorio, Purificación Cid‐Silva, Luís Morano et al. · Journal of Clinical Virology · 2017 · 30 citations

Hepatitis C, Elderly Patients, Viral Hepatitis +9

Effect of a Structured Pharmaceutical Care Intervention Versus Usual Care on Cardiovascular Risk in HIV Patients on Antiretroviral Therapy: INFAMERICA Study

Ramón Morillo‐Verdugo, María de las Aguas Robustillo Cortés, Maria Teresa Martín-Conde et al. · Annals of Pharmacotherapy · 2018 · 30 citations